Response to first course of intensified immunosuppression in genetically stratified steroid resistant nephrotic syndrome
Clinical Journal of the American Society of Nephrology | Jul 15, 2020
Urinary lithogenic risk profile in ADPKD patients treated with tolvaptan
Clinical Journal of the American Society of Nephrology | Jul 14, 2020
Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan
Journal of the American Society of Nephrology | Jun 06, 2020
Most read this week